175 related articles for article (PubMed ID: 32872014)
1. Safety and efficacy of apatinib combined with iodine-125 in chemotherapy-refractory advanced lung cancer: A case report.
Zhang Y; Yin S; Jia Y; Qin L
Medicine (Baltimore); 2020 Aug; 99(33):e21600. PubMed ID: 32872014
[TBL] [Abstract][Full Text] [Related]
2. Significant efficacy and well safety of apatinib combined with radiotherapy in NSCLC: Case report.
Zhao C; Zhang Q; Qiao W
Medicine (Baltimore); 2017 Dec; 96(50):e9276. PubMed ID: 29390380
[TBL] [Abstract][Full Text] [Related]
3. Apatinib combined with chemotherapy or concurrent chemo-brachytherapy in patients with recurrent or advanced cervical cancer: A phase 2, randomized controlled, prospective study.
Guo Q; Sun Y; Kong E; Rao L; Chen J; Wu Q; Zhang T; Liu N; Li M; Sun L
Medicine (Baltimore); 2020 Mar; 99(11):e19372. PubMed ID: 32176061
[TBL] [Abstract][Full Text] [Related]
4. Combination of computed tomography-guided iodine-125 brachytherapy and bronchial arterial chemoembolization for locally advanced stage III non-small cell lung cancer after failure of concurrent chemoradiotherapy.
Chen C; Wang W; Yu Z; Tian S; Li Y; Wang Y
Lung Cancer; 2020 Aug; 146():290-296. PubMed ID: 32615523
[TBL] [Abstract][Full Text] [Related]
5. Concurrent apatinib and local radiation therapy for advanced gastric cancer: A case report and review of the literature.
Zhang M; Deng W; Cao X; Shi X; Zhao H; Duan Z; Lv B; Liu B
Medicine (Baltimore); 2017 Mar; 96(9):e6241. PubMed ID: 28248891
[TBL] [Abstract][Full Text] [Related]
6. Combination of Iodine-125 brachytherapy and chemotherapy for locally recurrent stage III non-small cell lung cancer after concurrent chemoradiotherapy.
Yu X; Li J; Zhong X; He J
BMC Cancer; 2015 Oct; 15():656. PubMed ID: 26445227
[TBL] [Abstract][Full Text] [Related]
7. Concurrent computed tomography-guided radioactive iodine-125 seeds percutaneous interstitial implantation and chemotherapy for treatment of cervical lymph node metastases.
Li Z; Wang X; Fang K; Shi J; Qi X; Sun R
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1163-S1169. PubMed ID: 30539864
[TBL] [Abstract][Full Text] [Related]
8. Low dose of apatinib in treating chemotherapy and EGFR-TKI refractory non-small cell lung cancer: A case report.
Liu J; Zheng Y; Xu N
Medicine (Baltimore); 2019 Feb; 98(5):e14328. PubMed ID: 30702616
[TBL] [Abstract][Full Text] [Related]
9. Apatinib for advanced nonsmall-cell lung cancer: A retrospective case series analysis.
Yang C; Feng W; Wu D
J Cancer Res Ther; 2018 Jan; 14(1):159-162. PubMed ID: 29516980
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment using apatinib with or without docetaxel in heavily pretreated advanced non-squamous non-small cell lung cancer: A case report and literature review.
Wu F; Zhang S; Gao G; Zhao J; Ren S; Zhou C
Cancer Biol Ther; 2018 Mar; 19(3):141-144. PubMed ID: 29261000
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, safety, and prognostic factors of apatinib plus platinum doublet chemotherapy in advanced non-small cell lung cancer.
Xu J; Liu X; Yang S; Shi Y
J Cancer Res Ther; 2022 Sep; 18(5):1425-1431. PubMed ID: 36204892
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and Survival Analysis of Apatinib in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer after Failure of First-line Treatment].
Wang X; Zhang W; Du W; Zhang X; Ren X; Cao S
Zhongguo Fei Ai Za Zhi; 2017 Nov; 20(11):761-768. PubMed ID: 29167006
[TBL] [Abstract][Full Text] [Related]
13. Apatinib monotherapy for advanced non-small cell lung cancer after the failure of chemotherapy or other targeted therapy.
Liu Z; Ou W; Li N; Wang SY
Thorac Cancer; 2018 Oct; 9(10):1285-1290. PubMed ID: 30126078
[TBL] [Abstract][Full Text] [Related]
14. Continuous Low-Dose Apatinib Combined With WBRT Significantly Reduces Peritumoral Edema and Enhances the Efficacy of Symptomatic Multiple Brain Metastases in NSCLC.
Ren Y; Wang SB; Zhou L; Liu SQ; Du LY; Li T; Jiang MQ; Lei KJ; Tan BX; Jia YM
Technol Cancer Res Treat; 2021; 20():15330338211011968. PubMed ID: 33955301
[TBL] [Abstract][Full Text] [Related]
15. Long-term response with low-dose of apatinib combined with S-1 in pretreated patient with advanced squamous cell lung cancer: A case report.
Chen J; Wang J; Zou Y
Medicine (Baltimore); 2021 Feb; 100(8):e24390. PubMed ID: 33663051
[TBL] [Abstract][Full Text] [Related]
16. Apatinib and fractionated stereotactic radiotherapy for the treatment of limited brain metastases from primary lung mucoepidermoid carcinoma: A case report.
Yan H; Li X; Peng Y; Zhang P; Zou N; Liu X
Medicine (Baltimore); 2020 Oct; 99(43):e22925. PubMed ID: 33120847
[TBL] [Abstract][Full Text] [Related]
17. Clinical investigation of the efficacy and toxicity of apatinib (YN968D1) in stage III/IV non-small cell lung cancer after second-line chemotherapy treatment: A retrospective study.
Zhang D; Zhang C; Huang J; Guan Y; Guo Q
Thorac Cancer; 2018 Dec; 9(12):1754-1762. PubMed ID: 30338916
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of iodine-125 radioactive seeds brachytherapy for advanced non-small cell lung cancer-A meta-analysis.
Zhang W; Li J; Li R; Zhang Y; Han M; Ma W
Brachytherapy; 2018; 17(2):439-448. PubMed ID: 29275079
[TBL] [Abstract][Full Text] [Related]
19. Low dosage of apatinib monotherapy as rescue treatment in advanced lung squamous cell carcinoma.
Zeng DX; Lei W; Wang CG; Huang JA; Jiang JH
Cancer Chemother Pharmacol; 2019 Mar; 83(3):439-442. PubMed ID: 30547193
[TBL] [Abstract][Full Text] [Related]
20. Apatinib is effective as third-line and more treatment of advanced metastatic non-small-cell lung cancer: A retrospective analysis in a real-world setting.
Leng J; Li DR; Huang LM; Ji XH; Wang DL
Medicine (Baltimore); 2019 Sep; 98(36):e16967. PubMed ID: 31490378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]